Organon Pharma Indonesia Tbk PT banner
O

Organon Pharma Indonesia Tbk PT
IDX:SCPI

Watchlist Manager
Organon Pharma Indonesia Tbk PT
IDX:SCPI
Watchlist
Price: 29 000 IDR -7.2% Market Closed
Market Cap: Rp104.4B

Profitability Summary

Organon Pharma Indonesia Tbk PT's profitability score is 54/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

54 / 100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

54 / 100
Profitability
Score
54 / 100
Profitability
Score

Margins

Earnings Waterfall
Organon Pharma Indonesia Tbk PT

Margins Comparison
Organon Pharma Indonesia Tbk PT Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
ID
Organon Pharma Indonesia Tbk PT
IDX:SCPI
104.4B IDR
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
883.9B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
585.2B USD
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
237.5B GBP
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
299.1B USD
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
236.4B CHF
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
237.1B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
161B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
120B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Organon Pharma Indonesia Tbk PT Competitors

Country Company Market Cap ROE ROA ROCE ROIC
ID
Organon Pharma Indonesia Tbk PT
IDX:SCPI
104.4B IDR
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
883.9B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
585.2B USD
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
237.5B GBP
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
299.1B USD
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
236.4B CHF
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
237.1B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
161B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
120B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Organon Pharma Indonesia Tbk PT

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett